Journal of Medicinal Chemistry
Brief Article
(cord factor) and living bacillus Calmette Guerin. Science 1971, 174,
1240−1242.
(6) Furukawa, M.; Ohtsubo, Y.; Sugimoto, N.; Katoh, Y.; Dohi, Y.
Induction of tumoricidal activated macrophages by a liposome-
encapsulated glycolipid, trehalose 2,3,6′-trimycolate from Gordona
aurantiaca. FEMS Microbiol. Immunol. 1990, 2, 83−88.
(7) Natsuhara, Y.; Oka, S.; Kaneda, K.; Kato, Y.; Yano, I. Parallel
antitumor, granuloma-forming and tumor-necrosis-factor-priming
activities of mycoloyl glycolipids from Nocardia rubra that differ in
carbohydrate moiety: structure−activity relationships. Cancer Immunol.
Immunother 1990, 31, 99−106.
(8) Orbach-Arbouys, S.; Tenu, J. P.; Petit, J. F. Enhancement of in
vitro and in vivo antitumor activity by cord factor (6,6-dimycolate of
trehalose) administered suspended in saline. Int. Arch. Allergy Appl.
Immunol. 1983, 71, 67−73.
(9) Ribi, E.; Granger, D. L.; Milner, K. C.; Yamamoto, K.; Strain, S.
M.; Parker, R.; Smith, R. W.; Brehmer, W.; Azuma, I. Induction of
resistance to tuberculosis in mice with defined components of
mycobacteria and with some unrelated materials. Immunology 1982,
46, 297−305.
(10) Sharma, A.; Upadhyay, S. N. Cellular immune responsiveness in
rabbits with Setaria digitata filarial antigen and TDM adjuvant. Int. J.
Immunopharmacol. 1993, 15, 395−400.
(11) Sakaguchi, I.; Ikeda, N.; Nakayama, M.; Kato, Y.; Yano, I.;
Kaneda, K. Trehalose 6,6-dimycolate (cord factor) enhances neo-
vascularization through vascular endothelial growth factor production
by neutrophils and macrophages. Infect. Immun. 2000, 68, 2043−2052.
(12) Saita, N.; Fujiwara, N.; Yano, I.; Soejima, K.; Kobayashi, K.
Trehalose 6,6-dimycolate (cord factor) of Mycobacterium tuberculosis
induces corneal angiogenesis in rats. Infect. Immun. 2000, 68, 5991−
5997.
(13) Kunkel, S. L.; Chensue, S. W.; Strieter, R. M.; Lynch, J. P.;
Remick, D. G. Cellular and molecular aspects of granulomatous
inflammation. Am. J. Respir. Cell Mol. Biol. 1989, 1, 439−447.
(14) Orme, I. M. The immunopathogenesis of tuberculosis: a new
working hypothesis. Trends Microbiol. 1998, 6, 94−97.
(22) Ishihara, C.; Miyazawa, M.; Nishio, J.; Azuma, I.; Chesebro, B.
Use of low toxicity adjuvants and killed virus to induce protective
immunity against the Friend murine leukaemia retrovirus-induced
disease. Vaccine 1992, 10, 353−356.
(23) Saito, R.; Tanaka, A.; Sugiyama, K.; Azuma, I.; Yamamura, Y.
Adjuvant effect of cord factor, a mycobacterial lipid. Infect. Immun.
1976, 13, 776−781.
(24) Watanabe, R.; Yoo, Y. C.; Hata, K.; Motobe, M.; Koike, Y.;
Nishizawa, M.; García, D. M.; Noguchi, Y.; Imagawa, H.; Yamada, H.;
Azuma, I. Inhibitory effect of trehalose dimycolate (TDM) and
(TDCMs), with low toxicity on lung metastasis of tumour cells in
mice. Vaccine 1999, 17, 1484−1492.
(25) Ioneda, T.; Lenz, M.; Pudles, J. Chemical constitution of a
glycolipid from C. diphtheriae P.W.B. Biochem. Biophys. Res. Commun.
1963, 13, 110−114.
́
(26) Senn, M.; Ioneda, T.; Pudles, J.; Lederer, E. Spectrometrie de
masse de glycolipides 1. Structure du “cord factor” de Corynebacterium
diphtheriae. Eur. J. Biochem. 1967, 1, 353−356.
(27) Datta, A. K.; Takayama, K. Isolation and purification of
trehalose 6-mono- and 6,6-di-corynomycolates from Corynebacterium
1
matruchotii. Structural characterization by H NMR. Carbohydr. Res.
1993, 245, 151−158.
(28) Nishizawa, M.; Minagawa, R.; García, D. M.; Hatakeyama, S.;
Yamada, H. Syntheses and characterization of four diastereomers of
trehalose-6,6′-dicorynomycolates (TD BH32). Tetrahedron Lett. 1994,
35, 5891−5894.
(29) Nishizawa, M.; García, D. M.; Minagawa, R.; Noguchi, Y.;
Imagawa, H.; Yamada, H.; Watanabe, R.; Yoo, Y. C.; Azuma, I.
Effective synthesis of four isomeric trehalose dicorynomycolates
(TDCMs) and their immunoadjuvant activities. Synlett 1996, 452−
454.
̀
(30) Nishizawa, M.; Yamamoto, H.; Imagawa, H.; Chassefiere, V. B.;
Petit, E.; Azuma, I.; Papy-García, D. Efficient syntheses of a series of
trehalose dimycolate (TDM)/trehalose dicorynomycolate (TDCM)
analogues and their interleukin-6 level enhancement activity in mice
sera. J. Org. Chem. 2007, 72, 1627−1633.
́
(31) Durand, H.; Welby, M.; Laneelle, G.; Tocanne, J.-F. Phase
(15) Yarkoni, E.; Rapp, H. J. Granuloma formation in lungs of mice
after intravenous administration of emulsified trehalose-6,6′-dimyco-
late (cord factor): reaction intensity depends on size distribution of
the oil droplets. Infect. Immun. 1977, 18, 552−554.
(16) Andersen, C. S.; Agger, E. M.; Rosenkrands, I.; Gomes, J. M.;
Bhowruth, V.; Gibson, K. J. C.; Petersen, R. V.; Minnikin, D. E.; Besra,
G. S.; Andersen, P. A simple mycobacterial monomycolated glycerol
lipid has potent immunostimulatory activity. J. Immunol. 2009, 182,
424−432.
(17) Didierlaurent, A. M.; Morel, S.; Lockman, L.; Giannini, S. L.;
Bisteau, M.; Carlsen, H.; Kielland, A.; Vosters, O.; Vanderheyde, N.;
Schiavetti, F.; Larocque, D.; Van Mechelen, M.; Garco̧ n, N. AS04, an
behaviour of cord factor and related bacterial glycolipid toxins. Eur. J.
Biochem. 1979, 93, 103−112.
́
(32) Durand, H.; Gillois, M.; Tocanne, J.-F.; Laneelle, G. Property
and activity of mycoloyl esters of methyl glucoside and trehalose. Eur.
J. Biochem. 1979, 94, 109−118.
(33) Moody, D. B.; Guy, M. R.; Grant, E.; Cheng, T.-Y.; Brenner, M.
B.; Besra, G. S.; Porcelli, S. A. CD1b-mediated T cell recognition of a
glycolipid antigen generated from mycobacterial lipid and host
carbohydrate during Infection. J. Exp. Med. 2000, 192, 965−976.
(34) Imagawa, H.; Tsuchihashi, T.; Singh, R. K.; Yamamoto, H.;
Sugihara, T.; Nishizawa, M. Triethyl- (or trimethyl-) silyl triflate-
catalyzed reductive cleavage of triphenylmethyl (trityl) ethers with
triethylsilane. Org. Lett. 2003, 5, 153−155.
aluminum salt- and TLR4 agonist-based adjuvant system, induces a
transient localized innate immune response leading to enhanced
adaptive immunity. J. Immunol. 2009, 183, 6186−6197.
(35) Callegan, M. C.; Jett, B. D.; Hancock, L. E.; Gilmore, M. S. Role
of hemolysin BL in the pathogenesis of extra-intestinal Bacillus cereus
infection assessed in an endophthalmitis model. Infect. Immun. 1999,
67, 3357−3366.
(36) We found that IL-6 and MIP-1β are released from macrophages
treated with TDCM.
(37) Beutler, B.; Greenwald, D.; Hulmes, J. D.; Chang, M.; Pan, Y.
C.; Mathison, J.; Ulevitch, R.; Cerami, A. Identity of tumour necrosis
factor and the macrophage-secreted factor cachectin. Nature 1985,
316, 552−554.
(38) Mortelmans, K.; Zeiger, E. The Ames Salmonella/microsome
mutagenicity assay. Mutat. Res. 2000, 455, 29−60.
(39) Nagler-Anderson, C. Man the barrier! strategic defences in the
intestinal mucosa. Nature Rev. Immunol. 2001, 1, 59−67.
(40) Neutra, M. R.; Frey, A.; Kraehenbuhl, J.-P. Epithelial M cells:
Gateways for mucosal infection and immunization. Cell 1996, 86,
345−348.
(18) Garco̧ n, N.; Chomez, P.; Van Mechelen, M. GlaxoSmithKline
adjuvant systems in vaccines: concepts, achievements and perspectives.
Expert Rev. Vaccines 2007, 6, 723−739.
(19) Martin, O. R.; Zhou, W.; Wu, X.; Front-Deschamps, S.; Moutel,
S.; Schindl, K.; Jeandet, P.; Zbaeren, C.; Bauer, J. A. Synthesis and
immunobiological activity of an original series of acyclic lipid a mimics
based on a pseudodipeptide backbone. J. Med. Chem. 2006, 49, 6000−
6014.
(20) Yang, H.-Z.; Xu, S.; Liao, X.-Y.; Zhang, S.-D.; Liang, Z.-L.; Liu,
B.-H.; Bai, J.-Y.; Jiang, C.; Ding, J.; Cheng, G.-F.; Liu, G. A novel
immunostimulator, N2-[α-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-iso-
glutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy
on the hepatitis B surface antigen. J. Med. Chem. 2005, 48, 5112−5122.
(21) Brandenburg, K.; Hawkins, L.; Garidel, P.; Andra, J.; Muller, M.;
̈
̈
Heine, H.; Koch, M. H. J.; Seydel, U. Structural polymorphism and
endotoxic activity of synthetic phospholipid-like amphiphiles. Bio-
chemistry 2004, 43, 4039−4046.
385
dx.doi.org/10.1021/jm3016443 | J. Med. Chem. 2013, 56, 381−385